SRSF2 and myelodysplastic syndrome: Studies revealed that there are also mRNA splicing events, particularly in SF3B1, U2AF1, and SRSF2, in hematological tumors such as chronic lymphocytic leukemia (CLL) and myelodysplastic syndrome (MDS) (25).